Abstract
Rationale: The prognostic significance of systemic inflammation markers has been regarded as an outcome predictor in patients with advanced cancer. However, few studies have explored its prognostic role according to different thresholds. Thus, this study aimed to evaluate the prognostic value of C-reactive protein (CRP), albumin, CRP/albumin ratio (CAR), and modified Glasgow Prognostic Score (mGPS) according to different thresholds in patients with cancer in palliative care.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
